Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/s0190-9622(03)01870-x | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The cortical vein opacification score (COVES) is independently associated with DSA ASITN collateral score.
AJNR Am J Neuroradiol
November 2024
From the Department of Radiology and Radiological Sciences (D.A.L., A.B.B., H.S., R.W., J.M., V.Y.), and Department of Neurology (A.E.H.), Johns Hopkins University, Baltimore, MD, USA; Department of Neuroradiology (D.A.L., S.A., M.K., A.T.R.), and Department of Biostatistics (S.W.), West Virginia University, Morgantown, WV, USA; Cooper Medical School of Rowan University (M.K.), Camden, NJ, USA; Department of Neurology (J.J.H., G.W.A.), Stanford University, Stanford, CA, USA; Department of Radiology (A.A.D.), Harvard Medical School, Boston, MA, USA; Department of Radiology, Neuroendovascular Division (T.D.F.), University Medical Center Münster, Germany; Department of Neuroradiology (M.W.), MD Anderson Medical Center, Houston, TX, USA; Department of Radiology (K.N.), University of California San Francisco, CA, USA.
: Pretreatment CTA-based Cortical Vein Opacification Score (COVES) has been shown to predict good functional outcomes at 90 days in patients with acute ischemic stroke secondary to large vessel occlusion (AIS-LVO). This is thought to be related to its ability to measure collateral status (CS). However, its association with the reference standard test, the DSA-based American Society of Interventional and Therapeutic Neuroradiology (ASITN) collateral score, has yet to be established.
View Article and Find Full Text PDFInterprofessional insights in Agitation in Alzheimer's disease: An interview with the experts from Emory Integrated Memory Care.
Geriatr Nurs
October 2024
Director of Strategic Alliances, Gerontological Society of America, Washington, DC. Electronic address:
Agitation in Alzheimer's disease (AAD) is a troubling condition experienced by many of the 6.9 million people living with Alzheimer's disease in the United States. The Gerontological Society of America (GSA) initially published an evidence-based care pathway to treat this condition, Agitation in Alzheimer's Disease: A Decision Tree for Healthcare Providers, in 2022 and updated this resource in 2023 with the International Psychogeriatric Association (IPA) consensus definition of agitation.
View Article and Find Full Text PDFAortic Outcome after Implementation of a Treatment Strategy for Type B Aortic Dissection Involving the Aortic Arch.
Ann Vasc Surg
January 2025
Department of Cardiothoracic Surgery, St. Bartholomew's Hospital, London, UK; Department of Surgery and Interventional Sciences, University College London, London, UK.
Objective: To evaluate the outcomes achieved after implementing a treatment strategy for non-A non-B (NANB) (B 1-2 D according to the latest consensus document of the Society of Vascular Surgery (SVS) and Society of Thoracic Surgeons (STS) acute aortic dissection (AAD)).
Methods: This retrospective observational study adhered to the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) checklist. All cases of NANB AAD (B 1-2 D) treated at our institution between January 2016 and December 2022 were reviewed.
This article investigates the leader-following secure output consensus (LFSOC) problem of the heterogeneous multiagent systems (MASs) under the hybrid cyber-attacks. A novel hybrid cyber-attack model consisting of aperiodic additive deception (AAD) attacks and aperiodic denial of service (ADoS) attacks is proposed for characterizing cyber-attacks in a real network, where the aperiodicity is reflected in the fact that the duration of each cyber-attack can be different. First, a compensator is introduced for each agent to estimate the leader's state.
View Article and Find Full Text PDFDeveloping a questionnaire for assessing clinician- and patient-reported outcomes in actinic keratosis: Results from an expert panel.
JAAD Int
September 2024
Global Medical Affairs, Almirall SA, Barcelona, Spain.
Background: Current assessments on topical treatment attributes in actinic keratosis (AK) do not evaluate safety, effectiveness, and satisfaction from both clinician and patient perspectives, creating an unmet need for more comprehensive AK-specific measures that fully capture the patient experience.
Objective: To develop an actinic keratosis-specific expert panel questionnaire (AK-EPQ) of patient-reported outcomes and clinician-reported outcomes for use in research studies.
Methods: Using interviews of patients with AK and targeted literature reviews, a 9-person consensus panel of dermatologists with expertise in AK treatment was convened to develop the AK-EPQ to assess AK-specific patient-reported outcomes and clinician-reported outcomes.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!